Found 35 articles for: "Ivermectin"
Topical Ivermectin Is Associated With Improved Erythematotelangiectatic, Papulopustular, and Phymatous Rosacea in a Secondary Analysis
October 2023 | Volume 22 | Issue 10 | Editorials | 1063 | Copyright © October 2023
Rosacea has variable clinical presentation consisting of four overlapping phenotypes: erythematotelangiectatic, papulopustular, phymatous, and ocular.1 Rosacea's pathogenesis involves incre...
Read MoreThe Patient-Physician Relationship and Adherence: Observations From a Clinical Study
August 2023 | Volume 22 | Issue 8 | Editorials | 838 | Copyright © August 2023
Improved patient-physician relationships (PPR) are associated with better patient satisfaction and disease outcomes, however, there is limited literature assessing how PPR affects adherence in de...
Read MoreNeurogenic Rosacea Treatment: A Literature Review
June 2023 | Volume 22 | Issue 6 | Original Article | 566 | Copyright © June 2023
Rosacea is a chronic skin disorder involving central facial erythema secondary to vascular instability and cutaneous inflammation. Rosacea is divided into different subtypes based on the morpholo...
Read MoreTreatment and Maintenance of Cutaneous Rosacea in Latino Skin Types With Prescription Medications and Non-Prescription Cleansers and Moisturizers as Adjuncts: A Review
October 2022 | Volume 21 | Issue 10 | Original Article | 1111 | Copyright © October 2022
Background: Rosacea is an inflammatory dermatosis with at least a ten percent prevalence reported among white adults. Rosacea occurs in nonwhite populations, but prevalence data is li...
Read MoreSupplement Article: Skin Barrier Deficiency in Rosacea: An Algorithm Integrating OTC Skincare Products Into Treatment Regimens
September 2022 | Volume 21 | Issue 9 | Supplement Individual Articles | SF3595563 | Copyright © September 2022
Introduction: Rosacea is a chronic condition involving inflammation leading to a diminished skin barrier function in sebaceous gland-rich facial skin. The current algorithm represents...
Read MoreBullous Pemphigoid and Scabies: Is There an Association?
September 2022 | Volume 21 | Issue 9 | Original Article | 1009 | Copyright © September 2022
Background: Bullous Pemphigoid (BP) is an autoimmune subepithelial bullous disease. Several reports suggested an association between BP and scabies.
Objective: ...
Read MoreNovel Use of Topical Ivermectin for the Prevention of Facial Insect Bites
August 2022 | Volume 21 | Issue 8 | Editorials | 906 | Copyright © August 2022
Options to prevent facial insect bites while sleeping are limited. Patients may prefer to avoid facial application of potentially neurotoxic insect repellants. Non-toxic “natural” repellan...
Read MoreUpdate on Facial Erythema in Rosacea
August 2021 | Volume 20 | Issue 8 | Original Article | 861 | Copyright © August 2021
Dermatologists are cognizant of the multiple clinical manifestations of rosacea, particularly persistent facial erythema, which has been deemed to be the most prevalent diagnostic feature and often po...
Read MoreTreatment of Rhinophyma With Fractional CO2 Laser Resurfacing in a Woman of Color: Case Report and Review of the Literature
July 2021 | Volume 20 | Issue 7 | Case Reports | 772 | Copyright © July 2021
Rhinophyma is a disfiguring disorder that is characterized by an erythematous, hypertrophied, and inflamed lower two-thirds of the nose. Widely accepted as the severe form of acne rosacea, rhinophyma ...
Read MoreEvaluation of a First-in-Class Proteasome Inhibitor in Patients With Moderate to Severe Rosacea
June 2021 | Volume 20 | Issue 6 | Original Article | 660 | Copyright © June 2021
Background: Novel, effective, affordable therapies for rosacea are needed. Innovative methods of assessing response for rosacea treatments are needed as well. This trial was designed ...
Read MoreEvidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare Products into Treatment Regimens
April 2021 | Volume 20 | Issue 4 | Original Article | 384 | Copyright © April 2021
Background: Rosacea, an inflammatory skin disease that leads to an impaired skin barrier function commonly involves the face. Symptoms of rosacea can be bothersome and include pain, s...
Read MoreRationale for Use of Combination Therapy in Rosacea
October 2020 | Volume 19 | Issue 10 | Original Article | 929 | Copyright © October 2020
Background: Rosacea is a chronic skin condition characterized by primary and secondary manifestations affecting the centrofacial skin. The primary diagnostic phenotypes for rosacea ar...
Read MoreSystemic Medications of Dermatological Importance in COVID-19
September 2020 | Volume 19 | Issue 9 | Original Article | 889 | Copyright © September 2020
Early December 2019 witnessed an international outbreak of a novel coronavirus (COVID 19) designated severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). Since then, a number of therapeutic m...
Read MoreTreating Inflammation in Rosacea: Current Options and Unmet Needs
June 2020 | Volume 19 | Issue 6 | Original Article | 585 | Copyright © June 2020
Rosacea is a disease resulting from dysregulation of innate, adaptive, and neurovascular immune systems. Inflammatory pathways activated in rosacea can explain many of its signs and symptoms. Current ...
Read MoreRecognizing Rosacea: Tips on Differential Diagnosis
September 2019 | Volume 18 | Issue 9 | Original Article | 888 | Copyright © September 2019
Rosacea is a common chronic inflammatory dermatosis with a variety of clinical manifestations. Rosacea primarily affects the central face, and includes papules, pustules, erythema, telangiectasias, pe...
Read MorePatient-focused Solutions in Rosacea Management: Treatment Challenges in Special Patient Groups
July 2019 | Volume 18 | Issue 7 | Original Article | 608 | Copyright © July 2019
Rosacea is among the most common facial skin conditions diagnosed by dermatologists. Typical clinical features include erythema, flushing, telangiectasia, papules, and pustules distribut...
Read MoreSafety and Effectiveness of Microfocused Ultrasound for Treating Erythematotelangiectatic Rosacea
June 2019 | Volume 18 | Issue 6 | Original Article | 522 | Copyright © June 2019
Background: Anecdotal reports indicate the use of microfocused ultrasound with visualization (MFU-V) improves facial redness.
Objective: The purpose of th...
Read MoreThe Use of Oral Antibiotics in the Management of Rosacea
June 2019 | Volume 18 | Issue 6 | Original Article | 506 | Copyright © June 2019
Rosacea is common inflammatory facial dermatosis. Rosacea has variable manifestations including facial flushing, central facial erythema, telangiectasias, and papulopustular lesions. Treatment of rosa...
Read MoreWhat Is "PFE"? It May Just Be Time You Found Out....
June 2019 | Volume 18 | Issue 6 | Editorials | 503 | Copyright © June 2019
With all the literature and research we have on acne and rosacea, there are still many unanswered questions. Over time, as we uncover more information on both preexisting and newly recog...
Read MoreConcerns and Treatment Satisfaction in Patients Being Treated With Azelaic Acid Foam for Rosacea
April 2019 | Volume 18 | Issue 4 | Original Article | 381 | Copyright © April 2019
Objective: To describe patient characteristics, concerns, side effects, treatment satisfaction, and quality of life (QoL) of rosacea patients currently being treated with monotherapy azelaic acid ...
Read MoreMedia and other results for: "Ivermectin"
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.